NM_000497.3:c.1343G>A

Subject ID	Country of Origin	Allele Count	CTGA Clinical Significance	Condition(s)	Reference
202010.2.01	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.02	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.03	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.04	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.05	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.06	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.07	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.08	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.09	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.10	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991
202010.2.11	Morocco	2	Pathogenic	Adrenal Hyperplasia, Congenital, due to 11-Beta-Hydroxylase Deficiency	White et al. 1991

Epidemiology in the Arab World